• Amitriptyline HCl: Deep Profiling for Lipid Signaling and Ne

  2026-06-19

  Explore Amitriptyline HCl in advanced neuropharmacology with a focus on neurotransmitter receptor modulation and lipid-mediated neuroimmune pathways. This article uniquely bridges tricyclic antidepressant research with emerging insights from lipidomics.

• Betulinic Acid Mitigates Cyclophosphamide-Induced Liver Dama

  2026-06-18

  This study demonstrates that betulinic acid (BA) protects against cyclophosphamide-induced liver injury by suppressing oxidative stress and mitochondrial apoptosis, primarily through inhibition of the ERK–MAPK pathway. The findings provide mechanistic insight into BA’s hepatoprotective effects and highlight the utility of MEK inhibitors like PD98059 for dissecting related signaling mechanisms.

• MAPK10-Mediated KRT16 Degradation Suppresses NSCLC Metastasi

  2026-06-18

  The reference study identifies mitogen-activated protein kinase 10 (MAPK10) as a suppressor of non-small cell lung cancer (NSCLC) metastasis by driving phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). This mechanistic insight refines understanding of metastatic regulation and highlights the MAPK10/KRT16/RNF213 axis as a promising prognostic and therapeutic target.

• ATS-9R: Precision Gene Delivery to Adipocytes for Translatio

  2026-06-17

  Explore the mechanistic depth and translational promise of ATS-9R (Adipocyte-targeting sequence-9-arginine), a non-viral gene delivery oligopeptide enabling targeted, prohibitin-mediated nucleic acid delivery to white adipose tissue. This article synthesizes foundational research, competitive context, and advanced workflow guidance, positioning APExBIO's ATS-9R as a transformative tool for obesity and metabolic disease research. Evidence-driven insights and protocol recommendations empower translational scientists to unlock highly specific gene silencing strategies against the persistent challenges of obesity, insulin resistance, and adipocyte-driven inflammation.

• TBST (Tris-Buffered Saline and Tween 20) in Precision Immuno

  2026-06-17

  TBST's unique blend of Tris-buffered saline and Tween 20 delivers exceptional signal-to-noise ratio enhancement for antibody-based assays. Discover how APExBIO’s ready-to-use TBST streamlines immunoassay workflows, minimizes background noise, and offers critical troubleshooting advantages for reproducible, high-fidelity results.

• AG-221 (Enasidenib): Rewiring AML Metabolism for Translation

  2026-06-16

  This thought-leadership article dissects the mechanistic and translational landscape of AG-221 (Enasidenib) as a selective IDH2 inhibitor in acute myeloid leukemia (AML), with a sharp focus on metabolic rewiring and emerging therapeutic vulnerabilities. Bridging bench insights with clinical strategy, we highlight how innovations in metabolic targeting—anchored by the latest CD44-mediated rewiring discoveries—can drive next-generation research and therapeutic design for resistant hematologic malignancies.

• Diphenyleneiodonium Chloride: From Redox Probing to Translat

  2026-06-16

  This thought-leadership article explores Diphenyleneiodonium chloride (DPI) as a pivotal tool for dissecting redox enzyme function and cAMP signaling in translational research. Integrating mechanistic insights from Nrf2-focused studies and scenario-based guidance, it frames DPI’s strategic value for advancing oxidative stress, antiviral, and disease modeling workflows. The discussion bridges foundational cellular defense mechanisms with next-generation experimental design, offering actionable recommendations and a vision for translational maturity.

• Cucurbitacin I (JSI-124): Robust STAT3 Inhibitor for Cancer

  2026-06-15

  This article addresses key laboratory challenges in STAT3-related cancer research by providing scenario-driven guidance on the use of Cucurbitacin I (SKU A4512). It delivers actionable, evidence-based recommendations for improving assay reproducibility, sensitivity, and workflow reliability using this validated inhibitor.

• Cyclopamine (SKU A8340): Reliable Hedgehog Pathway Inhibitio

  2026-06-15

  This article explores laboratory challenges and best practices for using Cyclopamine (SKU A8340) as a Hedgehog signaling inhibitor in cancer and developmental biology research. Drawing on recent literature and validated protocols, we address assay design, data interpretation, and product selection, providing actionable guidance to ensure reproducible and sensitive results. APExBIO’s Cyclopamine is featured as a robust solution for demanding experimental workflows.

• Fangchinoline Restores Lysosomal Biogenesis to Block H1N1

  2026-06-14

  Cheng et al. demonstrate that fangchinoline restores TFEB-driven lysosomal biogenesis, thereby counteracting the lysosomal evasion strategies of H1N1 influenza virus. This work establishes lysosomal modulation as a promising direction for host-directed antiviral interventions.

• Peripheral Endosome Entrapment Limits LNP Cytosolic Delivery

  2026-06-13

  This study uncovers how lipid nanoparticles (LNPs) trapped in peripheral endosomes, rather than lysosomes, hinder intracellular trafficking and cytosolic release of RNA payloads. The findings clarify a key bottleneck in nucleic acid therapeutic delivery and highlight the need for improved assays to track endosomal escape.

• Streptavidin – Cy5: Advancing Biotin Detection in Breast Can

  2026-06-12

  This thought-leadership article examines the mechanistic and strategic value of Streptavidin – Cy5 for translational oncology, focusing on its role in high-sensitivity biotin detection within breast cancer apoptosis pathway studies. Integrating findings on USP42-mediated JNK/p38 inhibition, it provides actionable protocol parameters, competitive landscape insights, and a forward-looking perspective for translational researchers.

• Targeting Glutamine Metabolism in HSCs to Alleviate Liver Fi

  2026-06-12

  This article examines a study revealing that modulating glutamine metabolism in hepatic stellate cells (HSCs) via SIRT4 and glutamate dehydrogenase (GDH) control can attenuate liver fibrosis. The findings highlight new therapeutic opportunities for chronic liver diseases by targeting mitochondrial metabolic pathways.

• BOP Reagent: Precision Peptide Coupling & Synthesis Workflow

  2026-06-11

  BOP reagent (benzotriazol-1-yloxy-tris(dimethylamino)phosphanium hexafluorophosphate) is a potent peptide coupling agent enabling efficient amide bond formation and phenyl ester preparation. Its high purity and solubility in organic solvents streamline peptide synthesis. APExBIO's A7015 product is optimized for research use, with robust stability and reproducibility.

• Metronidazole for Research: OAT3 Inhibition & Anaerobe Targe

  2026-06-11

  Metronidazole, a potent OAT3 inhibitor and nitroimidazole antibiotic, empowers researchers to precisely dissect drug transport and microbiota interactions. Explore advanced experimental protocols, troubleshooting strategies, and translational opportunities that leverage APExBIO’s high-purity Metronidazole for robust, reproducible results.

450 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page